Development, Regulatory, & Outcomes (DRO) Network

Description & Goals

Network Goals

About DRO Network
The Development, Regulatory & Outcomes (DRO) Network brings together clinical pharmacologists, translational scientists, regulatory scientists, and outcomes researchers from industry, academia, government, and consulting. We work across the Discovery, Development, Regulation, and Utilization (DDRU) continuum, ensuring equitable access for all patients.

What We Do

Alignment to ASCPT's Strategic Plan 2026-2030

DRO Communities

Early Development & Drug Safety (EDDS) Focuses on first-in-human studies, dose selection, toxicology translation, and the pharmacological basis of drug safety assessment across early clinical development.	Regulatory Science (RS) Advances the science underlying drug evaluation and regulatory decision-making, supporting evidence-based approaches to drug approval, labeling, and post-market oversight.
Life Cycle Management (LCM) Addresses the scientific and regulatory dimensions of managing drug products throughout their commercial life, including new indications, formulations, and label updates.	Drug Utilization & Outcomes (DUO) Examines how medicines are used and what they achieve in real-world populations, integrating pharmacoepidemiology, health outcomes research, and comparative effectiveness.
Cell, Gene, Regenerative Medicine & Nucleic Acid (CGRN) Explores the clinical pharmacology of advanced therapeutic modalities, including cell therapies, gene therapies, and nucleic acid-based medicines, across development and regulation.	Global Health (GH) Promotes equitable access to safe and effective therapeutics worldwide, with a focus on clinical pharmacology in resource-limited settings.

Connect with Us
Have a question, idea, or interest in getting more involved? We want to hear from you! Email: members@ascpt.org Follow the DRO Network on LinkedIn. Visit individual Community pages to learn about specific areas of focus and upcoming activities. Engage with the DRO Network and our Communities directly at ASCPT Central.

Network Connection

Join the LinkedIn group.
Get Involved
The DRO Network is open to all ASCPT members with an interest in drug development, regulatory science, and outcomes research. Whether you are an established scientist or just beginning your career, there is a place for you here.

Complete the Invitation to Volunteer survey to indicate how you would like to volunteer with the DRO Network and its Communities.
Join a Community Steering Committee and help shape our programming and communication priorities.
Propose or co-develop a webinar on a topic relevant to your Community.
Submit a session proposal and/or abstract for the ASCPT Annual Meeting.
Nominate a colleague or yourself for leadership roles and/or ASCPT Awards.
Follow DRO on LinkedIn and ASCPT Central for updates, scientific highlights, and member spotlights.

DRO Network in Literature at ASCPT Central
Visit the DRO Network’s Library at ASCPT Central to access important resources like the paper below:
The DRO Network's commitment to pharmacoequity is documented in 2026 perspective published in Clinical Pharmacology & Therapeutics: "Advancing Pharmacoequity Globally: Reflections from the ASCPT Development, Regulatory, and Outcomes Network". The paper spotlights each community's contributions and identifies priority areas for building equitable health outcomes across the drug development continuum.

Past Webinars

The webinars below can be accessed in the Members Only Webinar Library: Access Library

Pre-Emptive Pharmacogenomic Testing Reduces the Risk of Adverse Drug Reactions by 30%: The Time for Implementation is Now
The Application of Model-Informed Drug Development in Rare Disease Development
Improving the Efficiency of Drug Development Through Clinical Data Leveraging: A Clinical Pharmacology Success Story in Schizophrenia
FDA's Sentinel System and the Regulatory Process